@FiercePharma: Warning to Roche execs: Don't drink too much at a conference. Your peers are watching (and may report you). More | Follow @FiercePharma
@EricPFierce: Yet another pharmaceutical supplier makes a move on India to get in on the growing market there. News | Follow @EricPFierce
@AlisonBFierce: Rising vaccine prices mean fewer children are immunized. But competition from small vaccine makers could lower costs. Story | Follow @AlisonBFierce
> Incentives from Nassau County on Long Island persuaded PL Developments, an OTC drugmaker and packaging manufacturer, to expand in the area, adding 150 jobs. Report
> Mylan ($MYL) distributed EpiPens, which combat severe allergic reactions, to thousands of schools in the U.S. Report
> The Generic Pharmaceutical Association elected Tony Mauro, president of Mylan North America, to serve as board chairman for a second year. Release
> Aspen Pharmacare expects an increase in earnings per share for the first half of its fiscal year. Report
> Perrigo ($PRGO) was sued by an AbbVie ($ABBV) subsidiary and Besins Healthcare for patent infringement over the OTC drugmaker's plans to sell a version of the testosterone drug Androgel. Report
> Florida Gov. Rick Scott has done an about-face on expanding Medicaid in his state, in a move that could add 1.2 million patients to the state's rolls over 10 years. Report
@FierceMedDev: Report: Middle East, North Africa poised for major device and Dx growth. Item | Follow @FierceMedDev
@MarkHFierce: Interesting challenge to the supremacy of surgical robots for a key procedure. News | Follow @MarkHFierce
@DamianFierce: Allergan won FDA approval for its new breast implant, but the agency wants quite a bit of post-market data. Story | Follow @DamianFierce
> Boston Scientific reaches into Japan with spinal deal. Article
> Cheap blood test measures Hodgkin lymphoma chemo success. More
Biotech News
@FierceBiotech: Ambit joins biotech IPO queue, seeks $58M as AML drug nears PhIII. News | Follow @FierceBiotech
@JohnCFierce: Manhandled by FDA in 2011, now a "no" in Europe. Gentium shares wrecked by fresh round of regulatory woes for lead drug. More | Follow @JohnCFierce
> Buzz: Shire's new CEO sends mixed signals on 'transformational' M&A strategy. Story
> Investors bankroll unique brains-and-beauty collaboration with $30M round. Article
Pharma Manufacturing News
> Drug shortages play role in growth at West Pharmaceutical. Story
> Mylan closes on oncology API plant as it rolls through India. Report
> China mandates track and trace while U.S. dithers. Article
> Dutch excipient player makes move on India. More
Vaccines News
> Rising vaccine prices mean fewer children immunized. News
> Indian court: Sanofi doesn't owe taxes on Shantha merger. Report
> Universal flu vaccine still 5 to 10 years away. Item
> HealthMap helps patients locate nearby vaccination sites. Article
> Australia begins vaccinating boys for HPV. Story
And Finally... The robot will see you now. Report